The Rx Inspector tool by ProPublica is a first-of-its-kind investigative database that allows users to trace generic prescription drugs back to the facilities where they were manufactured. Built from a large-scale investigative effort, the platform connects fragmented Food and Drug Administration (FDA) data to provide transparency into a system that has historically been difficult for the public to access.
Using information from a prescription label, users can search for a specific medication and identify the manufacturing plant, along with its inspection history and any documented safety or compliance issues. The database includes thousands of FDA inspection records and links them to drug production facilities, offering insight into quality concerns such as contamination risks, regulatory violations, or prior enforcement actions.
This tool is particularly valuable for patients, healthcare providers, researchers, and journalists seeking to understand the origins and safety record of generic medications. Because generic drugs account for the majority of prescriptions in the United States, yet often lack transparent sourcing information, Rx Inspector fills a critical gap by enabling informed decision-making and independent investigation.
For those engaged in public health advocacy, investigative reporting, or medical research, Rx Inspector provides a powerful way to analyze pharmaceutical supply chains, identify patterns in manufacturing quality, and hold regulatory systems accountable. It represents a major advancement in transparency around drug production and consumer safety.